Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?. Journal of Cancer Research Updates, [S. l.], v. 2, n. 4, p.  297–305, 2013. DOI: 10.6000/1929-2279.2013.02.04.8. Disponível em: https://neoplasiaresearch.com/index.php/jcru/article/view/427. Acesso em: 25 oct. 2025.